+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Facial Fat Transfer Market (2019-2025)

  • ID: 4987576
  • Report
  • January 2020
  • Region: Global
  • 140 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan PLC
  • Cytori Therapeutics, Inc.
  • Ipsen Pharma Biotech SAS
  • Ranfac Corporation
  • Scivision Biotech, Inc.
  • Suneva Medical, Inc.
  • MORE
The Global Facial Fat Transfer Market size is expected to reach3.5 billion by 2025, rising at a market growth of 10.4% CAGR during the forecast period. Facial fat transfer is also referred to as fat injection, fat grafting, or lipofilling. This is done by using the patient's body fat from the thighs, hips, or stomach to add volume to the face. Facial fat transfer is commonly done to restore sunken cheeks and hollow eyes, reduce wrinkles, thin lips, smooth deep nasolabial folds, and redefine the face. The industry is growing at a rapid pace owing to an increased demand for facial fat transfer procedure, advanced facial rejuvenation technology, and a growing aging population.

Facial fat injections may reduce parts of the facial "wear and tear" that are commonly shown with age, such as frown lines, marionette lines, smile lines, furrows and wrinkles, and hollows in the face, for example, under the cheekbones or the eyes. Lips with a lack of volume can also be treated by fat transfer, such as scars or depressions in the face from scars, such as those from the skin break out. People with at least one of these conditions may be good candidates for autologous fat transfer. Fat recovery time differs from patient to patient; however, most people should take a minimum of 7-10 days off from work and other social activities. The initial healing will take a few weeks, after which the swelling will slowly decrease before the final results are evident. Although the recovery period is relatively mild for fat transfer, patients must allow ample time to heal properly. Patients should see final results after about six months, while progress will begin to become evident just a few days after surgery.

The facial fat transfer market has gained immense market momentum due to its wide range of benefits to the patients. For example, since the fat used for grafting is derived from the patient's own body, there is almost no possibility of an adverse reaction, whereas the dermal filler-based hyaluronic acid has a possible risk of causing several allergic reactions. These benefits are also expected to drive the facial fat transfer market over the forecast period. Facial implant recovery is also a relatively mild process that needs at least a week of rest time before returning to work and other day-to-day activities. Exercise will be limited for a few weeks, and although the results should be immediately apparent, swelling will hinder the final results of the procedure at first. Swelling should begin to subside gradually and be fully resolved by approximately six months following the procedure.

Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.

Scope of the Study

Market Segmentation:

By Donor Site
  • Flank
  • Thigh
  • Abdomen
By End Use
  • Clinics & surgery centers
  • Hospitals
By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America
Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Allergan PLC
  • Integra LifeSciences Holdings Corporation
  • Bausch Health Companies, Inc.
  • Ipsen Pharma Biotech SAS
  • Ranfac Corporation
  • Cytori Therapeutics, Inc.
  • Suneva Medical, Inc.
  • Dr. Korman Laboratories Ltd.
  • Scivision Biotech, Inc.
  • Teoxane Laboratories SA
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan PLC
  • Cytori Therapeutics, Inc.
  • Ipsen Pharma Biotech SAS
  • Ranfac Corporation
  • Scivision Biotech, Inc.
  • Suneva Medical, Inc.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Facial Fat Transfer Market, by Donor Site
1.4.2 Global Facial Fat Transfer Market, by End Use
1.4.3 Global Facial Fat Transfer Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Facial Fat Transfer Market by Donor Site
3.1 Global Flank Facial Fat Transfer Market by Region
3.2 Global Thigh Facial Fat Transfer Market by Region
3.3 Global Abdomen Facial Fat Transfer Market by Region

Chapter 4. Global Facial Fat Transfer Market by End-Use
4.1 Global Clinics & surgery centers Market by Region
4.2 Global Hospitals Market by Region

Chapter 5. Global Facial Fat Transfer Market by Region
5.1 North America Facial Fat Transfer Market
5.1.1 North America Facial Fat Transfer Market by Donor Site
5.1.1.1 North America Flank Facial Fat Transfer Market by Country
5.1.1.2 North America Thigh Facial Fat Transfer Market by Country
5.1.1.3 North America Abdomen Facial Fat Transfer Market by Country
5.1.2 North America Facial Fat Transfer Market by End-Use
5.1.2.1 North America Clinics & surgery centers Market by Country
5.1.2.2 North America Hospitals Market by Country
5.1.3 North America Facial Fat Transfer Market by Country
5.1.3.1 US Facial Fat Transfer Market
5.1.3.1.1 US Facial Fat Transfer Market by Donor Site
5.1.3.1.2 US Facial Fat Transfer Market by End-Use
5.1.3.2 Canada Facial Fat Transfer Market
5.1.3.2.1 Canada Facial Fat Transfer Market by Donor Site
5.1.3.2.2 Canada Facial Fat Transfer Market by End-Use
5.1.3.3 Mexico Facial Fat Transfer Market
5.1.3.3.1 Mexico Facial Fat Transfer Market by Donor Site
5.1.3.3.2 Mexico Facial Fat Transfer Market by End-Use
5.1.3.4 Rest of North America Facial Fat Transfer Market
5.1.3.4.1 Rest of North America Facial Fat Transfer Market by Donor Site
5.1.3.4.2 Rest of North America Facial Fat Transfer Market by End-Use
5.2 Europe Facial Fat Transfer Market
5.2.1 Europe Facial Fat Transfer Market by Donor Site
5.2.1.1 Europe Flank Facial Fat Transfer Market by Country
5.2.1.2 Europe Thigh Facial Fat Transfer Market by Country
5.2.1.3 Europe Abdomen Facial Fat Transfer Market by Country
5.2.2 Europe Facial Fat Transfer Market by End-Use
5.2.2.1 Europe Clinics & surgery centers Market by Country
5.2.2.2 Europe Hospitals Market by Country
5.2.3 Europe Facial Fat Transfer Market by Country
5.2.3.1 Germany Facial Fat Transfer Market
5.2.3.1.1 Germany Facial Fat Transfer Market by Donor Site
5.2.3.1.2 Germany Facial Fat Transfer Market by End-Use
5.2.3.2 UK Facial Fat Transfer Market
5.2.3.2.1 UK Facial Fat Transfer Market by Donor Site
5.2.3.2.2 UK Facial Fat Transfer Market by End-Use
5.2.3.3 France Facial Fat Transfer Market
5.2.3.3.1 France Facial Fat Transfer Market by Donor Site
5.2.3.3.2 France Facial Fat Transfer Market by End-Use
5.2.3.4 Russia Facial Fat Transfer Market
5.2.3.4.1 Russia Facial Fat Transfer Market by Donor Site
5.2.3.4.2 Russia Facial Fat Transfer Market by End-Use
5.2.3.5 Spain Facial Fat Transfer Market
5.2.3.5.1 Spain Facial Fat Transfer Market by Donor Site
5.2.3.5.2 Spain Facial Fat Transfer Market by End-Use
5.2.3.6 Italy Facial Fat Transfer Market
5.2.3.6.1 Italy Facial Fat Transfer Market by Donor Site
5.2.3.6.2 Italy Facial Fat Transfer Market by End-Use
5.2.3.7 Rest of Europe Facial Fat Transfer Market
5.2.3.7.1 Rest of Europe Facial Fat Transfer Market by Donor Site
5.2.3.7.2 Rest of Europe Facial Fat Transfer Market by End-Use
5.3 Asia Pacific Facial Fat Transfer Market
5.3.1 Asia Pacific Facial Fat Transfer Market by Donor Site
5.3.1.1 Asia Pacific Flank Facial Fat Transfer Market by Country
5.3.1.2 Asia Pacific Thigh Facial Fat Transfer Market by Country
5.3.1.3 Asia Pacific Abdomen Facial Fat Transfer Market by Country
5.3.2 Asia Pacific Facial Fat Transfer Market by End-Use
5.3.2.1 Asia Pacific Clinics & surgery centers Market by Country
5.3.2.2 Asia Pacific Hospitals Market by Country
5.3.3 Asia Pacific Facial Fat Transfer Market by Country
5.3.3.1 China Facial Fat Transfer Market
5.3.3.1.1 China Facial Fat Transfer Market by Donor Site
5.3.3.1.2 China Facial Fat Transfer Market by End-Use
5.3.3.2 Japan Facial Fat Transfer Market
5.3.3.2.1 Japan Facial Fat Transfer Market by Donor Site
5.3.3.2.2 Japan Facial Fat Transfer Market by End-Use
5.3.3.3 India Facial Fat Transfer Market
5.3.3.3.1 India Facial Fat Transfer Market by Donor Site
5.3.3.3.2 India Facial Fat Transfer Market by End-Use
5.3.3.4 South Korea Facial Fat Transfer Market
5.3.3.4.1 South Korea Facial Fat Transfer Market by Donor Site
5.3.3.4.2 South Korea Facial Fat Transfer Market by End-Use
5.3.3.5 Singapore Facial Fat Transfer Market
5.3.3.5.1 Singapore Facial Fat Transfer Market by Donor Site
5.3.3.5.2 Singapore Facial Fat Transfer Market by End-Use
5.3.3.6 Malaysia Facial Fat Transfer Market
5.3.3.6.1 Malaysia Facial Fat Transfer Market by Donor Site
5.3.3.6.2 Malaysia Facial Fat Transfer Market by End-Use
5.3.3.7 Rest of Asia Pacific Facial Fat Transfer Market
5.3.3.7.1 Rest of Asia Pacific Facial Fat Transfer Market by Donor Site
5.3.3.7.2 Rest of Asia Pacific Facial Fat Transfer Market by End-Use
5.4 LAMEA Facial Fat Transfer Market
5.4.1 LAMEA Facial Fat Transfer Market by Donor Site
5.4.1.1 LAMEA Flank Facial Fat Transfer Market by Country
5.4.1.2 LAMEA Thigh Facial Fat Transfer Market by Country
5.4.1.3 LAMEA Abdomen Facial Fat Transfer Market by Country
5.4.2 LAMEA Facial Fat Transfer Market by End-Use
5.4.2.1 LAMEA Clinics & surgery centers Market by Country
5.4.2.2 LAMEA Hospitals Market by Country
5.4.3 LAMEA Facial Fat Transfer Market by Country
5.4.3.1 Brazil Facial Fat Transfer Market
5.4.3.1.1 Brazil Facial Fat Transfer Market by Donor Site
5.4.3.1.2 Brazil Facial Fat Transfer Market by End-Use
5.4.3.2 Argentina Facial Fat Transfer Market
5.4.3.2.1 Argentina Facial Fat Transfer Market by Donor Site
5.4.3.2.2 Argentina Facial Fat Transfer Market by End-Use
5.4.3.3 UAE Facial Fat Transfer Market
5.4.3.3.1 UAE Facial Fat Transfer Market by Donor Site
5.4.3.3.2 UAE Facial Fat Transfer Market by End-Use
5.4.3.4 Saudi Arabia Facial Fat Transfer Market
5.4.3.4.1 Saudi Arabia Facial Fat Transfer Market by Donor Site
5.4.3.4.2 Saudi Arabia Facial Fat Transfer Market by End-Use
5.4.3.5 South Africa Facial Fat Transfer Market
5.4.3.5.1 South Africa Facial Fat Transfer Market by Donor Site
5.4.3.5.2 South Africa Facial Fat Transfer Market by End-Use
5.4.3.6 Nigeria Facial Fat Transfer Market
5.4.3.6.1 Nigeria Facial Fat Transfer Market by Donor Site
5.4.3.6.2 Nigeria Facial Fat Transfer Market by End-Use
5.4.3.7 Rest of LAMEA Facial Fat Transfer Market
5.4.3.7.1 Rest of LAMEA Facial Fat Transfer Market by Donor Site
5.4.3.7.2 Rest of LAMEA Facial Fat Transfer Market by End-Use

Chapter 6. Company Profiles
6.1 Allergan PLC
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.2 Integra LifeSciences Holdings Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Ipsen Pharma Biotech SAS
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Ranfac Corporation
6.5.1 Company Overview
6.6 Cytori Therapeutics, Inc.
6.6.1 Company Overview
6.7 Suneva Medical, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Partnerships, Collaborations, and Agreements:
6.8 Dr. Korman Laboratories Ltd.
6.8.1 Company Overview
6.9 Scivision Biotech, Inc.
6.9.1 Company Overview
6.1 Teoxane Laboratories SA
6.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan PLC
  • Integra LifeSciences Holdings Corporation
  • Bausch Health Companies, Inc.
  • Ipsen Pharma Biotech SAS
  • Ranfac Corporation
  • Cytori Therapeutics, Inc.
  • Suneva Medical, Inc.
  • Dr. Korman Laboratories Ltd.
  • Scivision Biotech, Inc.
  • Teoxane Laboratories SA
Note: Product cover images may vary from those shown
Adroll
adroll